INmune Bio Inc. SEC filings and other documents

Explore the latest company documents and SEC filings from INmune Bio Inc., including Forms 10-K, 10-Q, 8-K, and other key disclosures. Evaluate financial performance and operational updates to make more informed decisions.

Description

Event date

Documents and forms

2025

Q2 2025

Aug 7, 2025

Earnings release8-K

Quarterly report10-Q

Slides

Transcript

Status Update

Jun 30, 2025

Press release

Q1 2025

May 8, 2025

Earnings release8-K

Quarterly report10-Q

Transcript

Corporate Presentation

Apr 3, 2025

Slides

Study Result

Feb 10, 2025

Transcript

2024

Q4 2024

Mar 27, 2025

Annual report10-K

Earnings release8-K

Transcript

Q3 2024

Oct 31, 2024

Earnings release8-K

Quarterly report10-Q

Q2 2024

Aug 1, 2024

Earnings release8-K

Quarterly report10-Q

Q1 2024

May 9, 2024

Earnings release8-K

Quarterly report10-Q

Investor Presentation

Feb 5, 2024

Slides

2023

Q4 2023

Mar 28, 2024

Annual report10-K

Earnings release8-K

Q3 2023

Nov 1, 2023

Earnings release8-K

Quarterly report10-Q

Q2 2023

Aug 7, 2023

Quarterly report10-Q

Investor Presentation

Jul 11, 2023

Slides

Q1 2023

May 3, 2023

Earnings release8-K

Quarterly report10-Q

2022

Q4 2022

Mar 2, 2023

Annual report10-K

Earnings release8-K

Q3 2022

Nov 2, 2022

Quarterly report10-Q

2021

Q4 2021

Mar 3, 2022

Annual report10-K

2020

Q4 2020

Mar 4, 2021

Annual report10-K

2019

Q4 2019

Mar 11, 2020

Annual report10-K

2018

Q4 2018

Mar 29, 2019

Annual report10-K